Spark Biomedical, Velentium Medical Team Up for New Femtech Wellness Product

Spark Biomedical and Velentium Medical—longtime partners in neuromodulation device development— are partnering to create OhmBody, a non-invasive wellness product for women. The pairing enables Spark Biomedical to expand into the rapidly growing femtech sector and underscores Velentium Medical’s solid market presence in full-service medical device design and manufacturing.

A news release about the collaboration said the new product is intended to help reduce cramps and unhealthy amounts of menstrual blood loss, as well as “provide support for other disruptive effects of a period like fatigue, gastric discomfort, and emotional fluctuations while supporting balance from the inside out.”

“We are honored to serve Spark Biomedical as their contract design and manufacturing organization of choice, and thrilled to help Spark Biomedical change women’s lives for a better world,” Velentium Medical CEO Matt Hanks stated.

The new product–OhmBody—is a discreet, wearable wellness device designed to support common menstrual challenges—without hormones or surgery. Comfortable, portable, and easy to use, OhmBody offers a science-backed, drug-free alternative for women seeking better options during their cycle.

“Velentium Medical has been an exceptional partner to Spark Biomedical for many years. Together, we collaborated on the design and manufacturing of both generations of our Sparrow device, which ultimately earned FDA clearance for opioid withdrawal treatment,” Spark Biomedical Co-Founer/CEO Daniel Powell said. “Now, as we expand our product line into the untapped market of women’s health, Velentium has once again been instrumental, helping us bring OhmBody to scale and deliver it to the masses.”

The opportunity in the emerging femtech space presents a significant untapped market. In menstrual care alone, the global market was estimated at $23.25 billion in 2024 and is projected to grow 6.98% annually through 2032, with consumer demand increasing for solutions that prioritize wellness, personalization, and non-invasive care, according to Fortune Business Insights.

Spark Biomedical Inc. is a U.S.-based medical device developer, committed to unlocking the potential of bioelectronic medicine and bringing to market novel wearable neurostimulation treatment options in neurological health, women’s health, and hemostasis. Spark leverages its neuroscience and engineering expertise to empower healthcare providers and researchers with evidence-based tools designed to address complex care situations that exceed the capabilities of existing treatment options. Spark has received funding from federal institutions such as the National Institutes of Health and U.S. Department of Defense, and continues to partner with private and academic institutions.

Velentium Medical is a full service CDMO, serving medtech clients worldwide to securely design, manufacture, and test class II and class III medical devices. Velentium Medical’s four units include research and development—pairing electronic and mechanical design, embedded firmware, mobile app development, and cloud systems with the human factor studies and systems engineering necessary to streamline medical device regulatory approval; contract manufacturing—building medical products at the prototype, clinical, and commercial levels in the Unite States as well as in low cost regions in 1345 certified and U.S. Food and Drug Administration (FDA)-registered Class VII clean rooms; cybersecurity—generating the 12 cybersecurity design artifacts required for FDA submission; and automated test systems, assuring that every device produced is exactly the same as the device that was approved.